LADENBURG THALMANN FINANCIAL SERVICES INC. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$47,000
+27.0%
5,852
+10.4%
0.00%
Q3 2019$37,000
-47.9%
5,303
-38.4%
0.00%
-100.0%
Q2 2019$71,000
-11.2%
8,603
+6.8%
0.00%0.0%
Q1 2019$80,000
+100.0%
8,053
+55.4%
0.00%
Q4 2018$40,000
+2.6%
5,183
+131.6%
0.00%
Q3 2018$39,000
+875.0%
2,238
+170.9%
0.00%
Q2 2018$4,0000.0%8260.0%0.00%
Q1 2018$4,0008260.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders